CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹26 Cr | ₹21 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of CONCORD DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹24 Cr |
How is Total Current Liabilities of CONCORD DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 24.64 | |
| Mar2024 | ₹21 Cr | -2.82 | |
| Mar2023 | ₹22 Cr | -8.59 | |
| Mar2022 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹92.7 Cr | 2% | -9.3% | 29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 2% |
-9.3% |
29.3% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses